HemoSonics has announced that its innovative Quantra Hemostasis Analyzer platform, and its initial QPlus cartridge have been granted de novo marketing authorization by the FDA and are now available for sale in the United States.
Many thanks to the attendees, speakers and organizers at the Society for the Advancement of Blood Management, Inc. (SABM) 2018 annual meeting in Brooklyn from 12-15 Sept. It was a top notch showing and an excellent educational experience for all of us!
HemoSonics will be participating in the scientific proceedings as well as have a commercial presence at Euroanesthesia (ESA), to be held in Copenhagen, Denmark on June 2-4th.
HemoSonics has announced the appointment of Remi Corlin, a 20-year medical device and diagnostic industry veteran, as VP International Markets to lead the rollout of the Quantra Hemostasis Analyzer in markets outside of the US.
HemoSonics has announced the presentation of scientific and clinical data at the XXVI International Society on Thrombosis and Hemostasis (ISTH) Congress in Berlin, Germany.
The Stago group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA).
